Feb 26
|
ClearPoint Neuro (CLPT) Gets FDA's Nod for New Software
|
Feb 26
|
Here's Why You Should Add Lantheus (LNTH) to Your Portfolio
|
Feb 26
|
Bruker's (BRKR) New Launches Drive Growth Amid FX Woes
|
Feb 26
|
Charles River (CRL) Forges Collaboration With Wheeler Bio
|
Jan 16
|
Here's Why Investors Should Retain Bruker (BRKR) Stock Now
|
Jan 16
|
Illumina (ILMN) Shares Down 1.2% Post Preliminary Q4 Results
|
Jan 16
|
Should Value Investors Buy DaVita (DVA) Stock?
|
Jan 16
|
Here's Why You Should Retain Masimo (MASI) Stock for Now
|
Jan 15
|
IDEXX (IDXX) Enhances Fecal Dx Antigen Testing Platform
|
Jan 15
|
Integer Holdings (ITGR) Hits 52-Week High: What's Driving It?
|
Jan 15
|
Veeva Systems (VEEV) Offerings Adopted by SK Life Science
|
Jan 15
|
Best Growth Stocks to Buy for January 15th
|
Jan 15
|
Beat the Market the Zacks Way: DaVita, Block, Home Depot in Focus
|
Jan 15
|
Quest Diagnostics (DGX) Inks New Deal With Ultima Genomics
|
Jan 12
|
Don't Overlook These Top Value Stocks in January It's Time to Buy
|
Jan 12
|
Here's Why You Should Retain Charles River (CRL) Stock Now
|
Jan 12
|
Inari (NARI) Preliminary Q4 Revenues Ride on Procedure Demand
|
Jan 12
|
Masimo (MASI) Posts Preliminary Q4 Results, Issues FY24 View
|
Jan 12
|
QIAGEN (QGEN) Wins FDA Clearance for NeuMoDx CT/NG Assay
|
Jan 11
|
Glaukos' (GKOS) Preliminary Q4 Revenues Ride on Product Demand
|